Sexual function in patients supported with left ventricular assist device and with heart transplant

Tal Hasin1,2, Tiny Jaarsma3, Daniel Murninkas1

  • 1Cardiology Department, Rabin Medical Center, Petah Tikva, Israel.

ESC Heart Failure
|August 24, 2017
PubMed

Insights

Sexual dysfunction is common in patients with left ventricular assist devices (LVADs), impacting quality of life more than after heart transplantation (HTx). Addressing physiological, psychological, and equipment issues is crucial for LVAD patients.

Area of Science:

  • Cardiology
  • Urology
  • Psychology

Background:

  • Sexual dysfunction is prevalent in heart failure (HF) patients, affecting quality of life.
  • Left ventricular assist device (LVAD) implantation improves survival in advanced HF, but its effect on sexual function is understudied.
  • Heart transplantation (HTx) is an alternative treatment for advanced HF.

Purpose of the Study:

  • To evaluate sexual function in patients with LVAD support.
  • To compare sexual function between LVAD patients and patients after HTx.
  • To identify factors contributing to sexual dysfunction in LVAD recipients.

Main Methods:

  • A validated questionnaire and visual analogue scale assessed sexual activity and satisfaction in stable LVAD and HTx patients.
  • Data were collected from 31 patients (17 HTx, 14 LVAD).
  • Statistical analysis compared outcomes between the two groups.

Main Results:

  • Sexual satisfaction was significantly higher in HTx patients (7.6/10) compared to LVAD patients (3.9/10).
  • Only 29% of LVAD patients reported satisfaction with sexual activity, versus 71% of HTx patients.
  • Common issues for LVAD patients included erectile dysfunction, vaginal dryness, device-related problems, and orgasmic difficulties.

Conclusions:

  • Sexual dysfunction is a significant issue for LVAD patients, potentially more pronounced than after HTx.
  • Physiological, psychological, and device-related factors contribute to sexual problems in LVAD recipients.
  • Comprehensive follow-up care for LVAD patients should address sexual health concerns.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
438
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
648